ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 165 filers reported holding ANIKA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $487,603 | +2.1% | 19,250 | +2.4% | 0.00% | – |
| Q1 2024 | $477,520 | +12.1% | 18,800 | 0.0% | 0.00% | – |
| Q4 2023 | $426,008 | +21.6% | 18,800 | 0.0% | 0.00% | – |
| Q3 2023 | $350,244 | -28.3% | 18,800 | 0.0% | 0.00% | – |
| Q2 2023 | $488,424 | -9.5% | 18,800 | 0.0% | 0.00% | – |
| Q1 2023 | $539,936 | -13.0% | 18,800 | -10.3% | 0.00% | – |
| Q4 2022 | $620,298 | +31.4% | 20,956 | +5.6% | 0.00% | – |
| Q3 2022 | $472,000 | +6.8% | 19,841 | +0.1% | 0.00% | – |
| Q2 2022 | $442,000 | -11.1% | 19,815 | +0.2% | 0.00% | – |
| Q1 2022 | $497,000 | -29.8% | 19,779 | +0.1% | 0.00% | – |
| Q4 2021 | $708,000 | -15.5% | 19,758 | +0.3% | 0.00% | – |
| Q3 2021 | $838,000 | -5.0% | 19,700 | -3.3% | 0.00% | – |
| Q2 2021 | $882,000 | -7.1% | 20,380 | -12.4% | 0.00% | – |
| Q1 2021 | $949,000 | +5.1% | 23,258 | +16.6% | 0.00% | – |
| Q4 2020 | $903,000 | +12.6% | 19,950 | -11.9% | 0.00% | – |
| Q3 2020 | $802,000 | -6.0% | 22,650 | +0.1% | 0.00% | -100.0% |
| Q2 2020 | $853,000 | +30.0% | 22,620 | -0.4% | 0.00% | – |
| Q1 2020 | $656,000 | -44.1% | 22,700 | +0.2% | 0.00% | -100.0% |
| Q4 2019 | $1,174,000 | -4.7% | 22,650 | +0.9% | 0.00% | 0.0% |
| Q3 2019 | $1,232,000 | +17.6% | 22,450 | -13.0% | 0.00% | 0.0% |
| Q2 2019 | $1,048,000 | +62.0% | 25,800 | +20.6% | 0.00% | – |
| Q1 2019 | $647,000 | -10.0% | 21,400 | 0.0% | 0.00% | -100.0% |
| Q4 2018 | $719,000 | -20.4% | 21,400 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $903,000 | +31.8% | 21,400 | 0.0% | 0.00% | – |
| Q2 2018 | $685,000 | -22.6% | 21,400 | +20.2% | 0.00% | -100.0% |
| Q1 2018 | $885,000 | -7.8% | 17,800 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $960,000 | -7.0% | 17,800 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $1,032,000 | +17.5% | 17,800 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $878,000 | +13.6% | 17,800 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $773,000 | -14.7% | 17,800 | -3.8% | 0.00% | 0.0% |
| Q4 2016 | $906,000 | +2.4% | 18,500 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $885,000 | -58.6% | 18,500 | -53.6% | 0.00% | -50.0% |
| Q2 2016 | $2,137,000 | +89.1% | 39,830 | +57.7% | 0.00% | +100.0% |
| Q1 2016 | $1,130,000 | +47.3% | 25,260 | +25.6% | 0.00% | 0.0% |
| Q4 2015 | $767,000 | +20.8% | 20,110 | +0.9% | 0.00% | 0.0% |
| Q3 2015 | $635,000 | -3.3% | 19,938 | +0.2% | 0.00% | 0.0% |
| Q2 2015 | $657,000 | -19.8% | 19,900 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $819,000 | +1.0% | 19,900 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $811,000 | +11.1% | 19,900 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $730,000 | -20.8% | 19,900 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $922,000 | +198.4% | 19,900 | +164.3% | 0.00% | – |
| Q1 2014 | $309,000 | +143.3% | 7,529 | +126.2% | 0.00% | – |
| Q4 2013 | $127,000 | +126.8% | 3,329 | +42.9% | 0.00% | – |
| Q3 2013 | $56,000 | -6.7% | 2,329 | -34.3% | 0.00% | – |
| Q2 2013 | $60,000 | – | 3,545 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Caligan Partners LP | 1,435,993 | $36,373,703 | 8.50% |
| Trigran Investments, Inc. | 2,136,232 | $54,110,757 | 5.66% |
| Stonepine Capital Management, LLC | 165,397 | $4,189,506 | 3.85% |
| Meros Investment Management, LP | 212,714 | $5,388,046 | 2.55% |
| Alta Fundamental Advisers LLC | 296,082 | $7,499,757 | 2.38% |
| CAPITAL MANAGEMENT CORP /VA | 328,620 | $8,323,945 | 1.67% |
| DIKER MANAGEMENT LLC | 56,239 | $1,424,534 | 1.21% |
| Virtus Investment Advisers, Inc. | 45,579 | $1,154,516 | 0.98% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 28,704 | $727,072 | 0.39% |
| BOOTHBAY FUND MANAGEMENT, LLC | 501,950 | $12,714,394 | 0.30% |